| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptidase activity | PAPPA2 CTSF TMPRSS13 CAPN6 SHH CTRB2 TMPRSS4 TMPRSS12 F2 F11 TMPRSS11B PRSS29P ADAMTS17 TMPRSS2 C2 SCPEP1 USP54 IHH CTRB1 ECE2 UFSP1 | 8.07e-08 | 654 | 162 | 21 | GO:0008233 |
| GeneOntologyMolecularFunction | endopeptidase activity | PAPPA2 CTSF TMPRSS13 CAPN6 SHH CTRB2 TMPRSS4 TMPRSS12 F2 F11 TMPRSS11B PRSS29P ADAMTS17 TMPRSS2 C2 CTRB1 ECE2 | 8.29e-08 | 430 | 162 | 17 | GO:0004175 |
| GeneOntologyMolecularFunction | serine-type peptidase activity | TMPRSS13 CTRB2 TMPRSS4 TMPRSS12 F2 F11 TMPRSS11B PRSS29P TMPRSS2 C2 SCPEP1 CTRB1 | 1.29e-07 | 207 | 162 | 12 | GO:0008236 |
| GeneOntologyMolecularFunction | serine hydrolase activity | TMPRSS13 CTRB2 TMPRSS4 TMPRSS12 F2 F11 TMPRSS11B PRSS29P TMPRSS2 C2 SCPEP1 CTRB1 | 1.67e-07 | 212 | 162 | 12 | GO:0017171 |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | TMPRSS13 CTRB2 TMPRSS4 TMPRSS12 F2 F11 TMPRSS11B PRSS29P TMPRSS2 C2 CTRB1 | 4.44e-07 | 190 | 162 | 11 | GO:0004252 |
| GeneOntologyMolecularFunction | acyl-CoA oxidase activity | 1.79e-05 | 7 | 162 | 3 | GO:0003997 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor | 6.03e-05 | 10 | 162 | 3 | GO:0016634 | |
| GeneOntologyMolecularFunction | interleukin-8 binding | 1.95e-04 | 3 | 162 | 2 | GO:0019959 | |
| GeneOntologyMolecularFunction | cholesterol-protein transferase activity | 1.95e-04 | 3 | 162 | 2 | GO:0140853 | |
| GeneOntologyMolecularFunction | oncostatin-M receptor activity | 1.95e-04 | 3 | 162 | 2 | GO:0004924 | |
| GeneOntologyMolecularFunction | palmitoyl-CoA oxidase activity | 3.88e-04 | 4 | 162 | 2 | GO:0016401 | |
| GeneOntologyMolecularFunction | FAD binding | 4.40e-04 | 44 | 162 | 4 | GO:0071949 | |
| GeneOntologyMolecularFunction | protein-lysine 6-oxidase activity | 6.44e-04 | 5 | 162 | 2 | GO:0004720 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 9.92e-04 | 310 | 162 | 9 | GO:0030246 | |
| GeneOntologyMolecularFunction | flavin adenine dinucleotide binding | 1.01e-03 | 94 | 162 | 5 | GO:0050660 | |
| GeneOntologyMolecularFunction | D-mannose binding | 1.33e-03 | 27 | 162 | 3 | GO:0005537 | |
| GeneOntologyMolecularFunction | C-X-C chemokine binding | 1.34e-03 | 7 | 162 | 2 | GO:0019958 | |
| GeneOntologyMolecularFunction | ciliary neurotrophic factor receptor binding | 1.34e-03 | 7 | 162 | 2 | GO:0005127 | |
| GeneOntologyBiologicalProcess | blood coagulation | VWF SHH F2 UBASH3A PAPSS2 F5 F8 F11 UBASH3B HPS5 VAV2 LILRB4 GP5 | 1.96e-07 | 260 | 166 | 13 | GO:0007596 |
| GeneOntologyBiologicalProcess | coagulation | VWF SHH F2 UBASH3A PAPSS2 F5 F8 F11 UBASH3B HPS5 VAV2 LILRB4 GP5 | 2.54e-07 | 266 | 166 | 13 | GO:0050817 |
| GeneOntologyBiologicalProcess | hemostasis | VWF SHH F2 UBASH3A PAPSS2 F5 F8 F11 UBASH3B HPS5 VAV2 LILRB4 GP5 | 2.77e-07 | 268 | 166 | 13 | GO:0007599 |
| GeneOntologyBiologicalProcess | response to wounding | VWF TNC SIGLEC16 SHH TMPRSS4 F2 UBASH3A PAPSS2 F5 F8 F11 BRAF SCARB1 UBASH3B CLEC10A HPS5 VAV2 LILRB4 GP5 | 1.59e-06 | 659 | 166 | 19 | GO:0009611 |
| GeneOntologyBiologicalProcess | negative regulation of cell activation | 1.01e-05 | 264 | 166 | 11 | GO:0050866 | |
| GeneOntologyBiologicalProcess | wound healing | VWF SHH F2 UBASH3A PAPSS2 F5 F8 F11 SCARB1 UBASH3B CLEC10A HPS5 VAV2 LILRB4 GP5 | 1.13e-05 | 493 | 166 | 15 | GO:0042060 |
| GeneOntologyBiologicalProcess | regulation of cell activation | FOXO3 SIGLEC16 SHH PGLYRP3 SHLD1 SOCS6 F2 GAL CD1D BRAF CLEC2D MLH1 LOXL3 PRKDC FGR IHH UBASH3B LILRB4 GP5 | 1.14e-05 | 756 | 166 | 19 | GO:0050865 |
| GeneOntologyBiologicalProcess | regulation of lymphocyte activation | FOXO3 SIGLEC16 SHH PGLYRP3 SHLD1 SOCS6 GAL CD1D BRAF CLEC2D MLH1 LOXL3 PRKDC FGR IHH LILRB4 | 3.80e-05 | 614 | 166 | 16 | GO:0051249 |
| GeneOntologyBiologicalProcess | negative regulation of immune system process | A2M SIGLEC16 SHH PGLYRP3 SOCS6 UBASH3A GAL TAX1BP1 CLEC2D LOXL3 PRKDC FGR IHH UBASH3B PADI2 LILRB4 | 5.25e-05 | 631 | 166 | 16 | GO:0002683 |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | VWF SHH F2 UBASH3A PAPSS2 F5 F8 F11 UBASH3B HPS5 VAV2 LILRB4 GP5 | 6.24e-05 | 442 | 166 | 13 | GO:0050878 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor catabolic process | 6.44e-05 | 2 | 166 | 2 | GO:1990172 | |
| GeneOntologyBiologicalProcess | fatty acid beta-oxidation using acyl-CoA oxidase | 1.07e-04 | 12 | 166 | 3 | GO:0033540 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte activation | FOXO3 SIGLEC16 SHH PGLYRP3 SHLD1 SOCS6 GAL CD1D BRAF CLEC2D MLH1 LOXL3 PRKDC FGR IHH LILRB4 | 1.58e-04 | 694 | 166 | 16 | GO:0002694 |
| GeneOntologyBiologicalProcess | protein splicing | 1.92e-04 | 3 | 166 | 2 | GO:0030908 | |
| GeneOntologyBiologicalProcess | mesenchymal-epithelial cell signaling involved in prostate gland development | 1.92e-04 | 3 | 166 | 2 | GO:0060739 | |
| GeneOntologyBiologicalProcess | intein-mediated protein splicing | 1.92e-04 | 3 | 166 | 2 | GO:0016539 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell activation | 2.17e-04 | 15 | 166 | 3 | GO:0032815 | |
| GeneOntologyBiologicalProcess | cell activation | FOXO3 VWF SIGLEC16 SHH PGLYRP3 SHLD1 SOCS6 F2 UBASH3A GAL CLEC4E CD1D BRAF CLEC2D MLH1 LOXL3 PRKDC FGR IHH UBASH3B HECTD1 VAV2 LILRB4 GP5 | 2.24e-04 | 1356 | 166 | 24 | GO:0001775 |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte differentiation | 2.25e-04 | 151 | 166 | 7 | GO:1902106 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte differentiation | 2.52e-04 | 70 | 166 | 5 | GO:0045620 | |
| GeneOntologyBiologicalProcess | negative regulation of hemopoiesis | 3.09e-04 | 159 | 166 | 7 | GO:1903707 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 3.14e-04 | 266 | 166 | 9 | GO:0045619 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte activation | 3.18e-04 | 211 | 166 | 8 | GO:0051250 | |
| GeneOntologyBiologicalProcess | regulation of immature T cell proliferation in thymus | 3.20e-04 | 17 | 166 | 3 | GO:0033084 | |
| GeneOntologyBiologicalProcess | T cell lineage commitment | 3.57e-04 | 42 | 166 | 4 | GO:0002360 | |
| GeneOntologyBiologicalProcess | regulation of immature T cell proliferation | 3.82e-04 | 18 | 166 | 3 | GO:0033083 | |
| GeneOntologyBiologicalProcess | oncostatin-M-mediated signaling pathway | 3.82e-04 | 4 | 166 | 2 | GO:0038165 | |
| GeneOntologyBiologicalProcess | bud outgrowth involved in lung branching | 3.82e-04 | 4 | 166 | 2 | GO:0060447 | |
| GeneOntologyBiologicalProcess | negative regulation of immune effector process | 4.00e-04 | 166 | 166 | 7 | GO:0002698 | |
| GeneOntologyBiologicalProcess | immature T cell proliferation in thymus | 4.51e-04 | 19 | 166 | 3 | GO:0033080 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | A2M NPHS1 COL6A2 CTSF VWF TNC LAMA2 SHH CPN2 F2 GDF10 ADAMTS17 LOXL4 LOXL3 USH2A ANGPTL5 | 6.18e-06 | 530 | 168 | 16 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | A2M NPHS1 COL6A2 CTSF VWF TNC LAMA2 SHH CPN2 F2 GDF10 ADAMTS17 LOXL4 LOXL3 IHH USH2A ANGPTL5 | 2.28e-05 | 656 | 168 | 17 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | A2M NPHS1 COL6A2 CTSF VWF TNC LAMA2 SHH CPN2 F2 GDF10 ADAMTS17 LOXL4 LOXL3 IHH USH2A ANGPTL5 | 2.37e-05 | 658 | 168 | 17 | GO:0030312 |
| GeneOntologyCellularComponent | cell surface | OTOA VWF SHH F2 PTGFRN ADCYAP1R1 LIFR PLA2R1 CLEC4E CD1D NEU1 PLPPR4 SCARB1 PKD1 CLEC2D PKHD1 ROS1 OSMR CLEC10A IL2RB CXCR1 LILRB4 GP5 | 2.93e-05 | 1111 | 168 | 23 | GO:0009986 |
| GeneOntologyCellularComponent | external side of plasma membrane | VWF F2 LIFR CLEC4E CD1D PLPPR4 CLEC2D PKHD1 OSMR CLEC10A IL2RB CXCR1 LILRB4 | 3.00e-04 | 519 | 168 | 13 | GO:0009897 |
| HumanPheno | Joint hemorrhage | 1.16e-06 | 17 | 61 | 5 | HP:0005261 | |
| HumanPheno | Menorrhagia | 4.70e-06 | 38 | 61 | 6 | HP:0000132 | |
| HumanPheno | Prolonged bleeding after dental extraction | 5.95e-06 | 23 | 61 | 5 | HP:0006298 | |
| HumanPheno | Persistent bleeding after trauma | 1.66e-05 | 28 | 61 | 5 | HP:0001934 | |
| HumanPheno | Prolonged bleeding following procedure | 3.28e-05 | 32 | 61 | 5 | HP:0011890 | |
| MousePheno | renal fibrosis | 9.53e-06 | 78 | 134 | 7 | MP:0003985 | |
| Domain | TRYPSIN_HIS | TMPRSS13 CTRB2 TMPRSS4 TMPRSS12 F2 F11 TMPRSS11B TMPRSS2 C2 CTRB1 | 2.15e-08 | 103 | 162 | 10 | IPR018114 |
| Domain | TRYPSIN_SER | TMPRSS13 CTRB2 TMPRSS4 TMPRSS12 F2 F11 TMPRSS11B TMPRSS2 C2 CTRB1 | 2.84e-08 | 106 | 162 | 10 | PS00135 |
| Domain | TRYPSIN_HIS | TMPRSS13 CTRB2 TMPRSS4 TMPRSS12 F2 F11 TMPRSS11B TMPRSS2 C2 CTRB1 | 3.11e-08 | 107 | 162 | 10 | PS00134 |
| Domain | Peptidase_S1A | TMPRSS13 CTRB2 TMPRSS4 TMPRSS12 F2 F11 TMPRSS11B TMPRSS2 C2 CTRB1 | 5.26e-08 | 113 | 162 | 10 | IPR001314 |
| Domain | TRYPSIN_DOM | TMPRSS13 CTRB2 TMPRSS4 TMPRSS12 F2 F11 TMPRSS11B TMPRSS2 C2 CTRB1 | 6.22e-08 | 115 | 162 | 10 | PS50240 |
| Domain | Tryp_SPc | TMPRSS13 CTRB2 TMPRSS4 TMPRSS12 F2 F11 TMPRSS11B TMPRSS2 C2 CTRB1 | 7.34e-08 | 117 | 162 | 10 | SM00020 |
| Domain | TRYPSIN_SER | 8.62e-08 | 90 | 162 | 9 | IPR033116 | |
| Domain | Trypsin_dom | TMPRSS13 CTRB2 TMPRSS4 TMPRSS12 F2 F11 TMPRSS11B TMPRSS2 C2 CTRB1 | 1.01e-07 | 121 | 162 | 10 | IPR001254 |
| Domain | Trypsin | TMPRSS13 CTRB2 TMPRSS4 TMPRSS12 F2 F11 TMPRSS11B TMPRSS2 C2 CTRB1 | 1.01e-07 | 121 | 162 | 10 | PF00089 |
| Domain | Peptidase_S1_PA | TMPRSS13 CTRB2 TMPRSS4 TMPRSS12 F2 F11 TMPRSS11B TMPRSS2 C2 CTRB1 | 1.18e-07 | 123 | 162 | 10 | IPR009003 |
| Domain | - | 2.24e-07 | 73 | 162 | 8 | 2.60.120.260 | |
| Domain | Galactose-bd-like | 1.59e-06 | 94 | 162 | 8 | IPR008979 | |
| Domain | - | 2.13e-06 | 25 | 162 | 5 | 3.10.250.10 | |
| Domain | SR | 2.13e-06 | 25 | 162 | 5 | SM00202 | |
| Domain | ACOX | 2.55e-06 | 4 | 162 | 3 | PF01756 | |
| Domain | Mib_Herc2 | 2.55e-06 | 4 | 162 | 3 | IPR010606 | |
| Domain | MIB_HERC2 | 2.55e-06 | 4 | 162 | 3 | PS51416 | |
| Domain | MIB_HERC2 | 2.55e-06 | 4 | 162 | 3 | PF06701 | |
| Domain | Acyl-CoA_oxidase_C | 2.55e-06 | 4 | 162 | 3 | IPR002655 | |
| Domain | Acyl-CoA_oxidase | 2.55e-06 | 4 | 162 | 3 | IPR012258 | |
| Domain | SRCR-like_dom | 2.62e-06 | 26 | 162 | 5 | IPR017448 | |
| Domain | SRCR_1 | 2.62e-06 | 26 | 162 | 5 | PS00420 | |
| Domain | SRCR_2 | 2.62e-06 | 26 | 162 | 5 | PS50287 | |
| Domain | SRCR | 3.19e-06 | 27 | 162 | 5 | IPR001190 | |
| Domain | FN3 | 5.02e-06 | 185 | 162 | 10 | SM00060 | |
| Domain | FN3_dom | 1.47e-05 | 209 | 162 | 10 | IPR003961 | |
| Domain | - | NPHS1 PAPPA2 FNDC3B FLT4 TNC NECTIN3 PTGFRN TGM5 LIFR CD1D PKHD1 ROS1 VSTM5 OSMR USH2A IL2RB MYBPC1 LILRB4 | 1.87e-05 | 663 | 162 | 18 | 2.60.40.10 |
| Domain | SRCR_2 | 2.19e-05 | 7 | 162 | 3 | PF15494 | |
| Domain | Ig-like_fold | NPHS1 PAPPA2 FNDC3B FLT4 TNC NECTIN3 PTGFRN TGM5 LIFR CD1D PKHD1 ROS1 VSTM5 OSMR USH2A IL2RB MYBPC1 LILRB4 | 4.27e-05 | 706 | 162 | 18 | IPR013783 |
| Domain | FN3 | 6.13e-05 | 199 | 162 | 9 | PS50853 | |
| Domain | INTEIN_N_TER | 7.48e-05 | 2 | 162 | 2 | PS50817 | |
| Domain | Factor_5/8 | 7.48e-05 | 2 | 162 | 2 | IPR024715 | |
| Domain | Acyl-CoA_ox_N | 7.48e-05 | 2 | 162 | 2 | PF14749 | |
| Domain | Intein_N | 7.48e-05 | 2 | 162 | 2 | IPR006141 | |
| Domain | Acyl-CoA_ox_N | 7.48e-05 | 2 | 162 | 2 | IPR029320 | |
| Domain | fn3 | 8.59e-05 | 162 | 162 | 8 | PF00041 | |
| Domain | SH3_1 | 9.36e-05 | 164 | 162 | 8 | PF00018 | |
| Domain | EGF_LAM_2 | 1.25e-04 | 30 | 162 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 1.25e-04 | 30 | 162 | 4 | PS01248 | |
| Domain | Ago_hook | 2.23e-04 | 3 | 162 | 2 | PF10427 | |
| Domain | Hedgehog_signalling_dom | 2.23e-04 | 3 | 162 | 2 | IPR000320 | |
| Domain | HintN | 2.23e-04 | 3 | 162 | 2 | SM00306 | |
| Domain | HintC | 2.23e-04 | 3 | 162 | 2 | SM00305 | |
| Domain | Hedgehog | 2.23e-04 | 3 | 162 | 2 | IPR001657 | |
| Domain | HH_signal | 2.23e-04 | 3 | 162 | 2 | PF01085 | |
| Domain | Hint | 2.23e-04 | 3 | 162 | 2 | PF01079 | |
| Domain | Hedgehog_sig/DD-Pept_Zn-bd_dom | 2.23e-04 | 3 | 162 | 2 | IPR009045 | |
| Domain | Hint_dom | 2.23e-04 | 3 | 162 | 2 | IPR001767 | |
| Domain | TNRC6_PABC-bd | 2.23e-04 | 3 | 162 | 2 | IPR032226 | |
| Domain | Argonaute_hook_dom | 2.23e-04 | 3 | 162 | 2 | IPR019486 | |
| Domain | TNRC6-PABC_bdg | 2.23e-04 | 3 | 162 | 2 | PF16608 | |
| Domain | - | 2.23e-04 | 3 | 162 | 2 | 3.30.1380.10 | |
| Domain | Hint_dom_N | 2.23e-04 | 3 | 162 | 2 | IPR003587 | |
| Domain | Hint_dom_C | 2.23e-04 | 3 | 162 | 2 | IPR003586 | |
| Domain | EGF_Lam | 2.32e-04 | 35 | 162 | 4 | SM00180 | |
| Domain | Laminin_EGF | 2.32e-04 | 35 | 162 | 4 | PF00053 | |
| Domain | UBA-like | 2.33e-04 | 64 | 162 | 5 | IPR009060 | |
| Domain | Acyl-CoA_Oxase/DH_cen-dom | 2.70e-04 | 15 | 162 | 3 | IPR006091 | |
| Domain | AcylCoA_DH/oxidase_NM_dom | 2.70e-04 | 15 | 162 | 3 | IPR009100 | |
| Domain | Acyl-CoA_dh_M | 2.70e-04 | 15 | 162 | 3 | PF02770 | |
| Domain | LAM_G_DOMAIN | 3.20e-04 | 38 | 162 | 4 | PS50025 | |
| Domain | Laminin_EGF | 3.20e-04 | 38 | 162 | 4 | IPR002049 | |
| Domain | Laminin_N | 3.30e-04 | 16 | 162 | 3 | IPR008211 | |
| Domain | LamNT | 3.30e-04 | 16 | 162 | 3 | SM00136 | |
| Domain | LAMININ_NTER | 3.30e-04 | 16 | 162 | 3 | PS51117 | |
| Domain | Laminin_N | 3.30e-04 | 16 | 162 | 3 | PF00055 | |
| Domain | AcylCo_DH/oxidase_C | 3.30e-04 | 16 | 162 | 3 | IPR009075 | |
| Domain | Laminin_G_2 | 3.91e-04 | 40 | 162 | 4 | PF02210 | |
| Domain | LamGL | 4.44e-04 | 4 | 162 | 2 | SM00560 | |
| Domain | LamG-like | 4.44e-04 | 4 | 162 | 2 | IPR006558 | |
| Domain | Hedgehog/Intein_dom | 4.44e-04 | 4 | 162 | 2 | IPR028992 | |
| Domain | - | 4.44e-04 | 4 | 162 | 2 | 2.170.16.10 | |
| Domain | LamG | 5.65e-04 | 44 | 162 | 4 | SM00282 | |
| Domain | SH3 | 6.06e-04 | 216 | 162 | 8 | SM00326 | |
| Domain | SH3 | 6.06e-04 | 216 | 162 | 8 | PS50002 | |
| Domain | C_TYPE_LECTIN_1 | 6.57e-04 | 80 | 162 | 5 | PS00615 | |
| Domain | SH3_domain | 6.83e-04 | 220 | 162 | 8 | IPR001452 | |
| Domain | Lysyl_oxidase | 7.35e-04 | 5 | 162 | 2 | IPR001695 | |
| Domain | - | 7.35e-04 | 5 | 162 | 2 | 3.90.1140.10 | |
| Domain | LYSYL_OXIDASE | 7.35e-04 | 5 | 162 | 2 | PS00926 | |
| Domain | Cu-oxidase_3 | 7.35e-04 | 5 | 162 | 2 | IPR011707 | |
| Domain | Lysyl_oxidase_CS | 7.35e-04 | 5 | 162 | 2 | IPR019828 | |
| Domain | MULTICOPPER_OXIDASE1 | 7.35e-04 | 5 | 162 | 2 | PS00079 | |
| Domain | Cu_oxidase_CS | 7.35e-04 | 5 | 162 | 2 | IPR033138 | |
| Domain | Lysyl_oxidase | 7.35e-04 | 5 | 162 | 2 | PF01186 | |
| Domain | Cu-oxidase_3 | 7.35e-04 | 5 | 162 | 2 | PF07732 | |
| Domain | FA58C | 7.60e-04 | 21 | 162 | 3 | SM00231 | |
| Domain | SRCR | 7.60e-04 | 21 | 162 | 3 | PF00530 | |
| Domain | FA58C_3 | 7.60e-04 | 21 | 162 | 3 | PS50022 | |
| Domain | FA58C_1 | 7.60e-04 | 21 | 162 | 3 | PS01285 | |
| Domain | FA58C_2 | 7.60e-04 | 21 | 162 | 3 | PS01286 | |
| Domain | LDLRA_1 | 7.88e-04 | 48 | 162 | 4 | PS01209 | |
| Domain | Lectin_C | 8.21e-04 | 84 | 162 | 5 | PF00059 | |
| Domain | CLECT | 8.21e-04 | 84 | 162 | 5 | SM00034 | |
| Domain | LDLRA_2 | 8.53e-04 | 49 | 162 | 4 | PS50068 | |
| Domain | C_TYPE_LECTIN_2 | 8.66e-04 | 85 | 162 | 5 | PS50041 | |
| Domain | Cupredoxin | 8.74e-04 | 22 | 162 | 3 | IPR008972 | |
| Domain | C-type_lectin-like | 9.13e-04 | 86 | 162 | 5 | IPR001304 | |
| Domain | Pkinase_Tyr | 9.18e-04 | 129 | 162 | 6 | PF07714 | |
| Domain | Cu_oxidase_Cu_BS | 1.10e-03 | 6 | 162 | 2 | IPR002355 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION | 4.43e-08 | 23 | 128 | 6 | M14766 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION | 4.43e-08 | 23 | 128 | 6 | MM14557 | |
| Pathway | REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE | 5.21e-08 | 39 | 128 | 7 | M2844 | |
| Pathway | REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE | 5.21e-08 | 39 | 128 | 7 | MM14559 | |
| Pathway | REACTOME_DEFECTS_OF_CONTACT_ACTIVATION_SYSTEM_CAS_AND_KALLIKREIN_KININ_SYSTEM_KKS | 2.30e-07 | 16 | 128 | 5 | M38996 | |
| Pathway | REACTOME_DISEASES_OF_HEMOSTASIS | 5.99e-07 | 19 | 128 | 5 | M48230 | |
| Pathway | WP_BLOOD_CLOTTING_CASCADE | 1.33e-06 | 22 | 128 | 5 | M39480 | |
| Pathway | WP_BLOOD_CLOTTING_CASCADE | 1.68e-06 | 23 | 128 | 5 | MM15936 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 2.92e-06 | 69 | 128 | 7 | M16894 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | TMPRSS13 MYO1E ACOX1 SHH PEX7 TMPRSS4 ACOX2 ACOX3 PLA2R1 SCARB1 TMPRSS2 LOXL4 LOXL3 CLEC10A | 9.30e-06 | 381 | 128 | 14 | M48063 |
| Pathway | REACTOME_DEFECTIVE_FACTOR_VIII_CAUSES_HEMOPHILIA_A | 2.49e-05 | 7 | 128 | 3 | M39000 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 5.02e-05 | 23 | 128 | 4 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 5.02e-05 | 23 | 128 | 4 | MM1427 | |
| Pathway | REACTOME_DEFECTIVE_FACTOR_IX_CAUSES_HEMOPHILIA_B | 5.90e-05 | 9 | 128 | 3 | M39001 | |
| Pathway | WP_SARSCOV2_AND_COVID19_PATHWAY | 8.38e-05 | 10 | 128 | 3 | M40050 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | A2M COL6A2 VWF TNC CAPN6 LAMA2 CTRB2 P4HA1 LOXL4 LOXL3 CTRB1 | 9.02e-05 | 300 | 128 | 11 | M610 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.21e-04 | 258 | 128 | 10 | MM14572 | |
| Pathway | WP_COMPLEMENT_AND_COAGULATION_CASCADES | 1.78e-04 | 58 | 128 | 5 | M39649 | |
| Pathway | WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES | 1.93e-04 | 59 | 128 | 5 | M48343 | |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 4.17e-04 | 39 | 128 | 4 | MM15272 | |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 4.60e-04 | 40 | 128 | 4 | M27557 | |
| Pathway | REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS | 7.24e-04 | 45 | 128 | 4 | M27623 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BETA_OXIDATION_PEROXISOME_VLCFA | 8.04e-04 | 5 | 128 | 2 | M49001 | |
| Pathway | REACTOME_FORMATION_OF_LATERAL_PLATE_MESODERM | 8.04e-04 | 5 | 128 | 2 | M46432 | |
| Pathway | REACTOME_COMMON_PATHWAY_OF_FIBRIN_CLOT_FORMATION | 9.93e-04 | 22 | 128 | 3 | M17879 | |
| Pathway | REACTOME_COMMON_PATHWAY_OF_FIBRIN_CLOT_FORMATION | 9.93e-04 | 22 | 128 | 3 | MM14558 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 9.93e-04 | 84 | 128 | 5 | M7098 | |
| Pubmed | 6.38e-09 | 257 | 171 | 12 | 16335952 | ||
| Pubmed | 1.17e-07 | 3 | 171 | 3 | 25592075 | ||
| Pubmed | 1.17e-07 | 3 | 171 | 3 | 20456758 | ||
| Pubmed | 1.17e-07 | 3 | 171 | 3 | 22032085 | ||
| Pubmed | 1.17e-07 | 3 | 171 | 3 | 20352152 | ||
| Pubmed | Prothrombotic polymorphisms in patients with Raynaud's phenomenon and migraine. | 4.65e-07 | 4 | 171 | 3 | 23238545 | |
| Pubmed | 2.31e-06 | 6 | 171 | 3 | 18457169 | ||
| Pubmed | LPCAT1 HECTD3 BTBD18 HAUS5 ADNP2 FBRSL1 TNRC6B ECT2L P4HA1 TNRC6A ZBTB10 MLH1 USP54 OSMR ASCC3 PADI2 CEP170B ILVBL GNL3 | 2.80e-06 | 1116 | 171 | 19 | 31753913 | |
| Pubmed | 4.03e-06 | 7 | 171 | 3 | 19682239 | ||
| Pubmed | An N-ethyl-N-nitrosourea screen for genes involved in variegation in the mouse. | 6.42e-06 | 8 | 171 | 3 | 15890782 | |
| Pubmed | A2M PAPPA2 CNKSR1 FLT4 VWF MTF2 STAM ACOX3 TAX1BP1 PKD1 HERC2 ASCC3 ZBTB3 | 8.05e-06 | 591 | 171 | 13 | 15231748 | |
| Pubmed | 9.60e-06 | 9 | 171 | 3 | 12615788 | ||
| Pubmed | UBAP2 JADE3 HAUS5 FBRSL1 WDR19 TRANK1 CELSR3 PLPPR4 TNRC6A HPS5 PADI2 NDRG4 | 1.34e-05 | 529 | 171 | 12 | 14621295 | |
| Pubmed | Hemostatic gene polymorphisms in young Sardinian with non-fatal acute myocardial infarction. | 1.37e-05 | 10 | 171 | 3 | 20036902 | |
| Pubmed | Development of migrating tendon-bone attachments involves replacement of progenitor populations. | 1.37e-05 | 10 | 171 | 3 | 30504126 | |
| Pubmed | 1.37e-05 | 10 | 171 | 3 | 15178647 | ||
| Pubmed | Targeting the p300/NONO axis sensitizes melanoma cells to BRAF inhibitors. | 1.40e-05 | 30 | 171 | 4 | 34017080 | |
| Pubmed | FOXO3 TNRC6B FRYL STAM BRAF TNRC6A PRKDC USP54 HECTD1 CEP170B ILVBL | 1.43e-05 | 446 | 171 | 11 | 24255178 | |
| Pubmed | FIP200 controls the TBK1 activation threshold at SQSTM1/p62-positive condensates. | 1.58e-05 | 223 | 171 | 8 | 34226595 | |
| Pubmed | UBAP2 DYNC2I1 TNRC6B NECTIN3 SLC6A8 P4HA1 TNRC6A SF3A3 TMF1 SCPEP1 USP54 HECTD1 TASOR GNL3 | 1.75e-05 | 733 | 171 | 14 | 34672954 | |
| Pubmed | Early embryonic expression of murine coagulation system components. | 2.33e-05 | 34 | 171 | 4 | 11154109 | |
| Pubmed | Lower birth-weight in neonates of mothers carrying factor V G1691A and factor II A(20210) mutations. | 2.40e-05 | 2 | 171 | 2 | 11836168 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 15731176 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 11183183 | ||
| Pubmed | Prevalence of factor V Leiden and prothrombin G20210A gene mutation. | 2.40e-05 | 2 | 171 | 2 | 15900364 | |
| Pubmed | Risk factors for catheter-related thrombosis in cancer patients. | 2.40e-05 | 2 | 171 | 2 | 15454250 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 26599105 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 32030746 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 16361766 | ||
| Pubmed | Basal cell carcinoma pathogenesis and therapy involving hedgehog signaling and beyond. | 2.40e-05 | 2 | 171 | 2 | 28574612 | |
| Pubmed | Thrombophilic risk factors in epileptic children treated with valproic Acid. | 2.40e-05 | 2 | 171 | 2 | 19135623 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 16818854 | ||
| Pubmed | The molecular basis of factor V and VIII procofactor activation. | 2.40e-05 | 2 | 171 | 2 | 19765210 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 33221577 | ||
| Pubmed | Are factor V and prothrombin mutations associated with increased risk of oral cancer? | 2.40e-05 | 2 | 171 | 2 | 16080493 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 22329698 | ||
| Pubmed | Mechano-covalent protection of coagulation factor VIII by von Willebrand factor. | 2.40e-05 | 2 | 171 | 2 | 36240294 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 11741359 | ||
| Pubmed | Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis. | 2.40e-05 | 2 | 171 | 2 | 18285537 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 23690449 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 21259017 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 11694407 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 16446869 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 22219226 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 18462012 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 18549909 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 17439630 | ||
| Pubmed | Prothrombotic factors and the risk of acute onset non-cardioembolic stroke in young Asian Indians. | 2.40e-05 | 2 | 171 | 2 | 19560187 | |
| Pubmed | Hedgehog can drive terminal differentiation of amniote slow skeletal muscle. | 2.40e-05 | 2 | 171 | 2 | 15238161 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 9218428 | ||
| Pubmed | The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor. | 2.40e-05 | 2 | 171 | 2 | 7756647 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 17067362 | ||
| Pubmed | Hemostatic and inflammatory risk factors for intracerebral hemorrhage in a pooled cohort. | 2.40e-05 | 2 | 171 | 2 | 18535282 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 16006096 | ||
| Pubmed | Maternal dietary choline deficiency alters angiogenesis in fetal mouse hippocampus. | 2.40e-05 | 2 | 171 | 2 | 20624989 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 22210734 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 17890946 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 18983482 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 18983490 | ||
| Pubmed | The influence of von Willebrand factor on factor VIII activity measurements. | 2.40e-05 | 2 | 171 | 2 | 18983499 | |
| Pubmed | Factor VIII and von Willebrand factor changes during normal pregnancy and puerperium. | 2.40e-05 | 2 | 171 | 2 | 14517489 | |
| Pubmed | Thrombogenic potential of picomolar coagulation factor XIa is mediated by thrombin wave propagation. | 2.40e-05 | 2 | 171 | 2 | 36724509 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 20489114 | ||
| Pubmed | TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. | 2.40e-05 | 2 | 171 | 2 | 32404436 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 28057741 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 20406709 | ||
| Pubmed | [Venous thromboembolic events in surgery: a role of genetic disorders]. | 2.40e-05 | 2 | 171 | 2 | 18368843 | |
| Pubmed | Meta-analysis of factor V Leiden and prothrombin G20210A polymorphism in migraine. | 2.40e-05 | 2 | 171 | 2 | 25158985 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 15471879 | ||
| Pubmed | Factor VLeiden and prothrombin G20210A gene polymorphisms in patients with coronary artery disease. | 2.40e-05 | 2 | 171 | 2 | 18452260 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 15735794 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 15072993 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 12413582 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 19356951 | ||
| Pubmed | [High-risk factors and clinical pathological analysis in 21 cases of fatal pulmonary embolism]. | 2.40e-05 | 2 | 171 | 2 | 20019774 | |
| Pubmed | Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischemic stroke. | 2.40e-05 | 2 | 171 | 2 | 15116266 | |
| Pubmed | New insight into hedgehog signaling in hematological malignancies. | 2.40e-05 | 2 | 171 | 2 | 24991722 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 20563311 | ||
| Pubmed | Thrombophilic polymorphism--a short-term or long-term risk for recurrence? | 2.40e-05 | 2 | 171 | 2 | 18983501 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 18777205 | ||
| Pubmed | Risk factors for post-thrombotic syndrome in patients with a first deep venous thrombosis. | 2.40e-05 | 2 | 171 | 2 | 18983518 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 26201092 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 20492463 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 20492466 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 14515183 | ||
| Pubmed | Differential requirements for shh in mammary tissue and hair follicle morphogenesis. | 2.40e-05 | 2 | 171 | 2 | 12217324 | |
| Pubmed | Increased factor VIII coagulant activity levels in male carriers of the factor V R2 polymorphism. | 2.40e-05 | 2 | 171 | 2 | 17287628 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 20528875 | ||
| Pubmed | Genomic cloning and partial characterization of human chymotrypsinogen gene. | 2.40e-05 | 2 | 171 | 2 | 8186414 | |
| Pubmed | Solution structure of the major factor VIII binding region on von Willebrand factor. | 2.40e-05 | 2 | 171 | 2 | 24700780 | |
| Pubmed | Thromboembolism in heart transplantation: role of prothrombin G20210A and factor V Leiden. | 2.40e-05 | 2 | 171 | 2 | 16177630 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 12008938 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 21940821 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 20937743 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 11919560 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 20337781 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 16973976 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 23349392 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 15033664 | ||
| Pubmed | Activated protein C has a regulatory role in factor VIII function. | 2.40e-05 | 2 | 171 | 2 | 33512448 | |
| Cytoband | 8q11 | 2.07e-04 | 6 | 172 | 2 | 8q11 | |
| Cytoband | 16q23.1 | 2.37e-04 | 32 | 172 | 3 | 16q23.1 | |
| Cytoband | 6q22 | 3.85e-04 | 8 | 172 | 2 | 6q22 | |
| GeneFamily | Proteases, serine | 3.41e-06 | 63 | 118 | 6 | 738 | |
| GeneFamily | Fibronectin type III domain containing | 1.01e-05 | 160 | 118 | 8 | 555 | |
| GeneFamily | C-type lectin domain family | 2.48e-04 | 47 | 118 | 4 | 494 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 4.17e-04 | 5 | 118 | 2 | 1157 | |
| GeneFamily | SH2 domain containing | 5.23e-04 | 101 | 118 | 5 | 741 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.12e-03 | 394 | 118 | 9 | 471 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 2.25e-03 | 40 | 118 | 3 | 592 | |
| Coexpression | NABA_MATRISOME | A2M PAPPA2 COL6A2 CTSF VWF TNC LAMA2 SHH CPN2 F2 GDF10 TGM5 CLEC4E NTNG2 P4HA1 CLEC2D ADAMTS17 LOXL4 LOXL3 IHH CLEC10A USH2A ANGPTL5 | 1.84e-07 | 1026 | 168 | 23 | M5889 |
| Coexpression | GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_DN | FNDC3B SUSD3 STAM F5 CD1D MICAL2 SCARB1 SCPEP1 CLEC10A NSMAF | 6.44e-07 | 198 | 168 | 10 | M8750 |
| Coexpression | NABA_MATRISOME | A2M PAPPA2 COL6A2 CTSF VWF TNC LAMA2 SHH CPN2 F2 GDF10 TGM5 CLEC4E NTNG2 P4HA1 CLEC2D ADAMTS17 LOXL4 LOXL3 IHH CLEC10A | 2.11e-06 | 1008 | 168 | 21 | MM17056 |
| Coexpression | NABA_ECM_REGULATORS | 3.39e-06 | 238 | 168 | 10 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 3.93e-06 | 242 | 168 | 10 | MM17062 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | A2M PAPPA2 CTSF SHH CPN2 F2 GDF10 TGM5 CLEC4E P4HA1 CLEC2D ADAMTS17 LOXL4 LOXL3 IHH CLEC10A ANGPTL5 | 7.24e-06 | 751 | 168 | 17 | M5885 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | A2M PAPPA2 CTSF SHH CPN2 F2 GDF10 TGM5 CLEC4E P4HA1 CLEC2D ADAMTS17 LOXL4 LOXL3 IHH CLEC10A | 2.30e-05 | 738 | 168 | 16 | MM17058 |
| Coexpression | PILON_KLF1_TARGETS_UP | A2M FOXO3 COL6A2 FLT4 VWF FRYL F2 ACOX2 WDR19 SLC6A8 LOXL4 IHH HECTD1 | 2.33e-05 | 503 | 168 | 13 | M2226 |
| Coexpression | HALLMARK_COAGULATION | 3.14e-05 | 138 | 168 | 7 | M5946 | |
| Coexpression | GSE36826_WT_VS_IL1R_KO_SKIN_UP | 4.21e-05 | 197 | 168 | 8 | M9537 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_UP | 4.52e-05 | 199 | 168 | 8 | M4494 | |
| Coexpression | PILON_KLF1_TARGETS_UP | A2M FOXO3 COL6A2 FLT4 VWF FRYL F2 ACOX2 WDR19 SLC6A8 LOXL4 IHH HECTD1 | 4.93e-05 | 541 | 168 | 13 | MM1061 |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S3 | 5.79e-05 | 266 | 168 | 9 | M1286 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LIVER_METASTASIS | 8.94e-05 | 14 | 168 | 3 | M48002 | |
| Coexpression | CERVERA_SDHB_TARGETS_2 | 1.00e-04 | 115 | 168 | 6 | M19068 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | FOXO3 GPRASP1 FNDC3B CTSF MANBA NAPEPLD TMPRSS13 JADE3 FBRSL1 PAPSS2 ZFPM2 SLC6A8 TRANK1 PLPPR4 P4HA1 MICAL2 SCARB1 LOXL3 UBASH3B CTRB1 PADI2 CEP170B | 1.18e-06 | 884 | 163 | 22 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_1000 |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-CD141-positive_myeloid_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.49e-08 | 131 | 172 | 8 | c48c4fb14b31908734bb0c44e1bd124b01df2a0b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.88e-08 | 143 | 172 | 8 | 57ee1830d96d73d92b5f83b028592a5d952c6013 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Myeloid-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-07 | 166 | 172 | 8 | 0a7992bc673fca546636563ec3fc17a4298ab6b1 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-07 | 175 | 172 | 8 | a9f88054e2c28d604c65ed785f63021aadb7f4c8 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-07 | 175 | 172 | 8 | 1b35acece23712ab7e3f92d9d68266efd38b3ef5 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-chondrocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.56e-07 | 177 | 172 | 8 | 915b848d789051a1c3bc6f6dc86955bb752276ab | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.96e-07 | 179 | 172 | 8 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-07 | 181 | 172 | 8 | 7286700396676fdc41d9723979b8b408177aceb9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-07 | 184 | 172 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-07 | 184 | 172 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 6.11e-07 | 184 | 172 | 8 | 684d05340a3dfb8aa08b881516a37f9627a10448 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-07 | 184 | 172 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.37e-07 | 185 | 172 | 8 | 7bff05d8d34616adbaa0ea0b69eb30aa906bb9f8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.91e-07 | 187 | 172 | 8 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.91e-07 | 187 | 172 | 8 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.91e-07 | 187 | 172 | 8 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.79e-07 | 190 | 172 | 8 | 212f0d9defcc3174e225cc3d90e7814e238794b6 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.84e-07 | 196 | 172 | 8 | d9b5eaca4089d5337f1175a663418c9c675cdd87 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-06 | 197 | 172 | 8 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-06 | 197 | 172 | 8 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Undetermined|Myeloid_cells / Location, Cell class and cell subclass | 1.02e-06 | 197 | 172 | 8 | 3ad72b70406e8a4c6996ec41809b174a423dad38 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-06 | 198 | 172 | 8 | 579a22199643440b98e381147779ced630d4ed66 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_CHIT1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-06 | 199 | 172 | 8 | 368e2bafae00ce8e9c6ea480f81b78f96b680acd | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.05e-06 | 151 | 172 | 7 | f13a117ae26ae525da4f3e837d8f204d00dc6ee3 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.32e-06 | 169 | 172 | 7 | 78eb70dd916724e476eabccf18fb7fcec4210308 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD1c+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 4.50e-06 | 170 | 172 | 7 | 403b6b749d70d845838dcda7daf99971b50792a2 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-06 | 181 | 172 | 7 | 269b39ac65790061d54eab47a8eeb024403f0348 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-06 | 181 | 172 | 7 | c8395ae872aa80b3ae1ab7c53e57b3ca15aeb0e2 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-06 | 181 | 172 | 7 | cd4f744b6b64ba6c22ec07afd1d3058a2546909d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.03e-06 | 182 | 172 | 7 | 904804813849b7f7f716ba1554d33b07bc0a701e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.03e-06 | 182 | 172 | 7 | 5d8b7fe18286e27f0f50c5d2d9be56850e2cb8f4 | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.55e-06 | 184 | 172 | 7 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.82e-06 | 185 | 172 | 7 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.82e-06 | 185 | 172 | 7 | 42690b95e2e7d56c822211bb1150acb787cfe2e8 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.10e-06 | 186 | 172 | 7 | 02418c50fdcca549bf73dedf6199ab4a27862a9b | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.10e-06 | 186 | 172 | 7 | d3509a579871ba6a8c4edd6137b28f271c9dbe70 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.10e-06 | 186 | 172 | 7 | 39e475a3c167b33daa63b0c1bfa32451c5f46635 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-osteoclast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.69e-06 | 188 | 172 | 7 | 762b52f21d2bc5409f86746a904c4358490be9c0 | |
| ToppCell | MS-mono3-|MS / Condition, Cell_class and T cell subcluster | 8.69e-06 | 188 | 172 | 7 | e8c1c2941ca4919e0097a65b692b7af8018e8886 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 8.69e-06 | 188 | 172 | 7 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | MS-mono3|MS / Condition, Cell_class and T cell subcluster | 8.69e-06 | 188 | 172 | 7 | a50a766c2f02e776c8e5c6e0833ec241c61831c4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.96e-06 | 192 | 172 | 7 | 314d94d676d13f4ca0eea8ba222c7eb00946849c | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.03e-05 | 193 | 172 | 7 | 44839a606ae2f8e37421bda46d588189e1c943d2 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.07e-05 | 194 | 172 | 7 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.18e-05 | 197 | 172 | 7 | 037f5f26fa66818baa35846aa96336155e8a6f45 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 197 | 172 | 7 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | critical-Myeloid|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.22e-05 | 198 | 172 | 7 | a5807517f8ca93b77f49f5787fd9036178b8fc2a | |
| ToppCell | 343B-Endothelial_cells|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-05 | 198 | 172 | 7 | fab32347580c7a81ef1fe4fe7b325d9105a947d9 | |
| ToppCell | critical-Myeloid-Neutrophil|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.22e-05 | 198 | 172 | 7 | 4da73dc3acb29d70b160903600d2bf7fdab34333 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-05 | 198 | 172 | 7 | 7608f67959e1cda7b10e57fd3af2f96216ebe7e9 | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.26e-05 | 199 | 172 | 7 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.26e-05 | 199 | 172 | 7 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | distal-1-mesenchymal-Myofibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.26e-05 | 199 | 172 | 7 | 58c36f5a30c6862b7f5587a0b9bc31da99e43dd5 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.30e-05 | 200 | 172 | 7 | 251fd2923f108cd2086961d897244b392c32ad54 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.30e-05 | 200 | 172 | 7 | efdf7066b7dd43e35dbc0d2719b75f250cf54af2 | |
| ToppCell | Severe-Myeloid-Macrophages-FCN1-SPP1+|Severe / Condition, Lineage, Cell class and cell subclass | 1.30e-05 | 200 | 172 | 7 | b8cd209b810312793465b28bb2a6cbe5d94da91f | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.30e-05 | 200 | 172 | 7 | cc3cdfc4636d8892500ce60518c5ccc100b9e5df | |
| ToppCell | P03-Hematopoietic|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.83e-05 | 141 | 172 | 6 | 4a856521520ea73291f4730fe94c5de88c2b6f0c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.23e-05 | 146 | 172 | 6 | 86cddd0e7f954547b7ffdccb0329cd5c4b725ac1 | |
| ToppCell | lung-Type_II_Pneumocytes|lung / shred on tissue and cell subclass | 2.32e-05 | 147 | 172 | 6 | 8a3039de45b8087f8319e2e37329acf7278219b7 | |
| ToppCell | P03-Hematopoietic-Immune-immune_cell_unspecified|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.50e-05 | 149 | 172 | 6 | 43d756f81d532b5c7f2306e6af9d072d496cbc8e | |
| ToppCell | P03-Hematopoietic-Immune|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.50e-05 | 149 | 172 | 6 | 1c5a2572741c47246d455c865e8e1677c9f49598 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-05 | 154 | 172 | 6 | 27f76e4b3c055aa382708f1610c685f02d6d6114 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-05 | 154 | 172 | 6 | 8746663a822d93a8510081c81a8c971b51653067 | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-granulocyte-granulocyte_l26|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.23e-05 | 156 | 172 | 6 | da5cfa8fa9595613f04ce9511f8b42bad34d995a | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.38e-05 | 95 | 172 | 5 | 56350551af6a1ae15652d596002124d8f7885d4f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.47e-05 | 158 | 172 | 6 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | droplet-Heart-nan-18m-Myeloid-cardiac_mast_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-05 | 158 | 172 | 6 | 9596b7b0f6f5157a43d67d2e67fb75a2624a6bb9 | |
| ToppCell | droplet-Heart-nan-18m-Myeloid-mast_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-05 | 158 | 172 | 6 | 7ebc8b778c97c0faa79e2d80c98b887fa635f901 | |
| ToppCell | droplet-Heart-nan-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-05 | 158 | 172 | 6 | 81a5a73090804d41429d297ba2462a842f39d380 | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage-macrophage-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.86e-05 | 161 | 172 | 6 | 5925ee646aa040550e3f8a164a13c8a5c0353319 | |
| ToppCell | normal_Lung-Myeloid_cells-Undetermined|Myeloid_cells / Location, Cell class and cell subclass | 3.86e-05 | 161 | 172 | 6 | 283012858e575c70d09950de53da041509f59bfa | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid|saliva / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.86e-05 | 161 | 172 | 6 | 1b5ebc82ee6166ecc2984648565f334cd69b636b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-05 | 162 | 172 | 6 | b502d6af6868425b5c919740e011330c0d3cf3b8 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.00e-05 | 162 | 172 | 6 | 16d625ac6702f79a83af444d2b3bf6759fd17cf6 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-05 | 163 | 172 | 6 | 1c4de36cf8cdaabb981cda5c7ce7e5ae7b4280e3 | |
| ToppCell | droplet-Liver-Hepatocytes-18m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-05 | 163 | 172 | 6 | 7e82c1b7849eca895732df2da74ac6430bd9ba7a | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-05 | 163 | 172 | 6 | 03d9fa615d9d02ef98e20f28a10aaa6894dd4960 | |
| ToppCell | facs-Trachea-nan-18m-Myeloid-granulocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 166 | 172 | 6 | 7f8b4cf63c3e292ae421f111edaa4572717f4db1 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 167 | 172 | 6 | ed7e785dcd25777f64e0c2596ada4f5a5ea17121 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.89e-05 | 168 | 172 | 6 | ba9ddd403ee6d6af2fe56dffbd419764bfb703e4 | |
| ToppCell | PND03-Immune-Immune_Myeloid|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.89e-05 | 168 | 172 | 6 | f7b911ed2d9d38bab6609da3c37e157ccf1c867b | |
| ToppCell | droplet-Bladder-nan-24m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-05 | 168 | 172 | 6 | c6e0daa790dd5db20dd1ab8c1e7142484976d743 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.89e-05 | 168 | 172 | 6 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 4.89e-05 | 168 | 172 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-classical_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.89e-05 | 168 | 172 | 6 | af4c35c0d3f030cef8397c35fa498a71112bb16b | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-05 | 169 | 172 | 6 | f00741203efa0b948db7223ee8c19bdd0918258a | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.06e-05 | 169 | 172 | 6 | 58e22f9119240664515fe91ca53812611a8f17d6 | |
| ToppCell | Control-T_cells-Tregs|Control / group, cell type (main and fine annotations) | 5.06e-05 | 169 | 172 | 6 | e1e0983f31ec81b3fad5f9c6140d17f03f81a5dc | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.06e-05 | 169 | 172 | 6 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.23e-05 | 170 | 172 | 6 | 985c2d5962100fab0d95bee39f382ccbe799331e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-05 | 171 | 172 | 6 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.58e-05 | 172 | 172 | 6 | e39ea2f4edbf36ebf9604fa6f9349081859c596c | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-05 | 172 | 172 | 6 | 2a4614b3d25e8c6b095e6992d8ca35371dcdb5e1 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.58e-05 | 172 | 172 | 6 | 875ea290840e835952623b905eb610f3c71456d2 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-05 | 172 | 172 | 6 | 7fb31ccbcd0204c3612986a6bc20d57ed6825e9c | |
| ToppCell | PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.58e-05 | 172 | 172 | 6 | bcc50bed47465daa953ba91f17d1ee4c947ab461 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.14e-05 | 175 | 172 | 6 | a5db428b078938627e61b7e944c1e0c1d61ac2da | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.14e-05 | 175 | 172 | 6 | 8b498eea1ec1c1f27b171025c3d08adf3687bafc | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 175 | 172 | 6 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| Drug | 0ZI | 2.84e-07 | 20 | 167 | 5 | CID000122235 | |
| Drug | non-2-enoic acid | 3.88e-07 | 3 | 167 | 3 | CID000097730 | |
| Drug | hexacosenoic acid | 4.76e-07 | 22 | 167 | 5 | CID006441476 | |
| Drug | EDTA | 7.02e-07 | 135 | 167 | 9 | CID000006049 | |
| Drug | B-1,3-od | 1.54e-06 | 4 | 167 | 3 | CID011971053 | |
| Drug | N-(4-carboxycyclohexylmethyl)-maleimide | 1.54e-06 | 4 | 167 | 3 | CID011548799 | |
| Drug | 2-methylhexanoyl-CoA | 1.54e-06 | 4 | 167 | 3 | CID009543276 | |
| Drug | PCA16 | 1.54e-06 | 4 | 167 | 3 | CID000131037 | |
| Drug | N-acetyl-LTE4 | 1.71e-06 | 28 | 167 | 5 | CID000004341 | |
| Drug | C4 m | 1.87e-06 | 79 | 167 | 7 | CID009543487 | |
| Drug | ethinyl estradiol-desogestrel combination | 2.46e-06 | 30 | 167 | 5 | ctd:C442659 | |
| Drug | glyphosine | 3.43e-06 | 32 | 167 | 5 | CID000017112 | |
| Drug | 2-methylpalmitate | 3.58e-06 | 15 | 167 | 4 | CID000117384 | |
| Drug | 3,4-pentadienoyl-CoA | 3.83e-06 | 5 | 167 | 3 | CID000196561 | |
| Drug | 2-(4-chlorophenoxy)butanoate | 3.83e-06 | 5 | 167 | 3 | CID000151501 | |
| Drug | tetracosahexaenoic acid | 7.63e-06 | 6 | 167 | 3 | CID006439582 | |
| Drug | Ak 10 | 7.63e-06 | 6 | 167 | 3 | CID006475489 | |
| Drug | LK-903 | 7.63e-06 | 6 | 167 | 3 | CID006443773 | |
| Drug | cobalt;(6E)-6-[[2-[[(E)-(6-oxocyclohexa-2,4-dien-1-ylidene)methyl]amino]ethylamino]methylene]cyclohexa-2,4-dien-1-one;hydrate | 7.63e-06 | 6 | 167 | 3 | CID011810022 | |
| Drug | S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (6R)-2-methyl-6-[(3R,5S,7R,8R,9S,10R,12S,13R,14S,17R)-3,7,12-trihydroxy-5,10,13-trimethyl-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]heptanethioate | 7.63e-06 | 6 | 167 | 3 | CID011966116 | |
| Drug | nonanoyl-CoA | 7.63e-06 | 6 | 167 | 3 | CID000193520 | |
| Drug | dicamba | 7.89e-06 | 18 | 167 | 4 | CID000003030 | |
| Drug | eicosapentaenoic acid ethyl ester | 7.89e-06 | 18 | 167 | 4 | ctd:C035276 | |
| Drug | D-Phe-Pro-Arg-CMK | 8.25e-06 | 38 | 167 | 5 | CID000439822 | |
| Drug | gamma-carboxyglutamic acid | 9.71e-06 | 101 | 167 | 7 | CID000040772 | |
| Drug | iodide | A2M FLT4 VWF CTRB2 F2 F11 ADCYAP1R1 GAL NEU1 BRAF SULT2A1 SCARB1 CTRB1 IL2RB CXCR1 | 9.80e-06 | 534 | 167 | 15 | CID000024841 |
| Drug | Pb-D | 1.09e-05 | 143 | 167 | 8 | CID000070065 | |
| Drug | Coagulation Factor IX | 1.33e-05 | 7 | 167 | 3 | DB00100 | |
| Drug | diallyl phthalate | 1.33e-05 | 7 | 167 | 3 | CID000008560 | |
| Drug | purpald | 1.33e-05 | 7 | 167 | 3 | CID002723946 | |
| Drug | benzamidine | 1.33e-05 | 147 | 167 | 8 | CID000002332 | |
| Drug | Sulfaguanidine [57-67-0]; Up 200; 18.6uM; PC3; HT_HG-U133A | 1.50e-05 | 196 | 167 | 9 | 4257_UP | |
| Drug | AC1NRA23 | 1.61e-05 | 73 | 167 | 6 | CID005287657 | |
| Drug | CHEMBL372561 | 1.61e-05 | 73 | 167 | 6 | CID011703683 | |
| Drug | 2,2-dimethylpentanoic acid | 2.11e-05 | 8 | 167 | 3 | CID000014455 | |
| Drug | dihydroxyacetophenone | 2.11e-05 | 8 | 167 | 3 | CID000099611 | |
| Drug | benzoxazinone analogue | 2.11e-05 | 8 | 167 | 3 | CID000468715 | |
| Drug | Bio-Phe-CH2Cl | 2.11e-05 | 8 | 167 | 3 | CID000083924 | |
| Drug | Bio-Arg-CH2Cl | 2.11e-05 | 8 | 167 | 3 | CID000083923 | |
| Drug | FPCoA | 2.11e-05 | 8 | 167 | 3 | CID000194677 | |
| Drug | gamma-decalactone | 2.11e-05 | 8 | 167 | 3 | CID000012813 | |
| Drug | AC1NBT2G | 3.13e-05 | 25 | 167 | 4 | CID004473289 | |
| Drug | pyrenebutyl methylphosphonofluoridate | 3.15e-05 | 9 | 167 | 3 | CID000125653 | |
| Drug | B316 | 3.15e-05 | 9 | 167 | 3 | CID000199983 | |
| Drug | FK-401 | 3.15e-05 | 9 | 167 | 3 | CID000135041 | |
| Drug | tlmE | 3.15e-05 | 9 | 167 | 3 | CID000188322 | |
| Drug | methyl ricinelaidate | 3.15e-05 | 9 | 167 | 3 | CID000008841 | |
| Drug | J 508 | 3.15e-05 | 9 | 167 | 3 | CID000155219 | |
| Drug | DDAVP | 3.50e-05 | 123 | 167 | 7 | CID000027991 | |
| Drug | Leupeptin hydrochloride | 3.87e-05 | 276 | 167 | 10 | CID000003910 | |
| Drug | AC1L8TCY | 4.30e-05 | 27 | 167 | 4 | CID000407798 | |
| Drug | 4-cis-decenoyl-CoA | 4.48e-05 | 10 | 167 | 3 | CID006443609 | |
| Drug | phosphatidylinositol 3,4,5-triphosphate | 4.48e-05 | 10 | 167 | 3 | ctd:C060974 | |
| Drug | 1i32 | 4.75e-05 | 129 | 167 | 7 | CID000446186 | |
| Drug | AC1NS51S | 4.98e-05 | 28 | 167 | 4 | CID005354165 | |
| Drug | AC1Q5PO8 | 4.98e-05 | 28 | 167 | 4 | CID000000642 | |
| Drug | NSC407322 | 5.24e-05 | 131 | 167 | 7 | CID000003977 | |
| Drug | tungstopterin | 5.24e-05 | 131 | 167 | 7 | CID005460240 | |
| Drug | BOCPheONP | 5.35e-05 | 2 | 167 | 2 | CID000111308 | |
| Drug | MPM-06 | 5.35e-05 | 2 | 167 | 2 | CID000161546 | |
| Drug | Anti-Retroviral Agents | 5.35e-05 | 2 | 167 | 2 | ctd:D044966 | |
| Drug | NSC-374899 | 5.35e-05 | 2 | 167 | 2 | CID000435726 | |
| Drug | methylbenzenebutanoate | 5.35e-05 | 2 | 167 | 2 | CID000281254 | |
| Drug | Asp-Arg-Val-Tyr-Val-His-Pro-Phe-His-Leu | 5.35e-05 | 2 | 167 | 2 | CID004418081 | |
| Drug | c189 | 5.35e-05 | 2 | 167 | 2 | CID000248048 | |
| Drug | dansyl-D-arginine methyl ester | 5.35e-05 | 2 | 167 | 2 | CID000191369 | |
| Drug | methyl 6-phenylhexanoate | 5.35e-05 | 2 | 167 | 2 | CID011820300 | |
| Drug | 5-aminotetrazole | 5.35e-05 | 2 | 167 | 2 | CID000020467 | |
| Drug | 2-bromoisobutyric acid | 5.35e-05 | 2 | 167 | 2 | CID000074924 | |
| Drug | p-toluamidine | 5.35e-05 | 2 | 167 | 2 | CID000122753 | |
| Drug | N-acetyl-alpha-azaphenylalanine phenyl ester | 5.35e-05 | 2 | 167 | 2 | CID000191275 | |
| Drug | isobutyl sulfide | 5.35e-05 | 2 | 167 | 2 | CID000011607 | |
| Drug | furoyl saccharin | 6.12e-05 | 11 | 167 | 3 | CID000064792 | |
| Drug | AGN 191701 | 6.12e-05 | 11 | 167 | 3 | CID006438168 | |
| Drug | phenindione | 6.12e-05 | 11 | 167 | 3 | CID000004760 | |
| Drug | C04760 | 6.12e-05 | 11 | 167 | 3 | CID000440469 | |
| Drug | GDP-Man | 7.98e-05 | 140 | 167 | 7 | CID000000732 | |
| Drug | FeCl3 | 8.10e-05 | 97 | 167 | 6 | CID000024380 | |
| Drug | anisylamine | 8.12e-05 | 12 | 167 | 3 | CID000075452 | |
| Drug | Drotrecogin alfa | 8.12e-05 | 12 | 167 | 3 | DB00055 | |
| Drug | Ertiprotafib | 8.12e-05 | 12 | 167 | 3 | CID000157049 | |
| Drug | AC1NORN3 | 8.12e-05 | 12 | 167 | 3 | CID005118011 | |
| Drug | AC1NOS53 | 8.12e-05 | 12 | 167 | 3 | CID005118245 | |
| Drug | AC1L19UW | 8.55e-05 | 32 | 167 | 4 | CID000000714 | |
| Drug | Nilutamide [63612-50-0]; Down 200; 12.6uM; HL60; HT_HG-U133A | 9.26e-05 | 193 | 167 | 8 | 3104_DN | |
| Drug | H2DIDS | 9.68e-05 | 33 | 167 | 4 | CID000115184 | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.03e-04 | 196 | 167 | 8 | 2225_DN | |
| Drug | phenyl 4-guanidinobenzoate | 1.05e-04 | 13 | 167 | 3 | CID003015798 | |
| Drug | AC1NORMX | 1.05e-04 | 13 | 167 | 3 | CID005118009 | |
| Drug | BAEE | 1.07e-04 | 64 | 167 | 5 | CID000123880 | |
| Drug | tranexamic acid | 1.07e-04 | 64 | 167 | 5 | CID000005526 | |
| Drug | FFRck | 1.09e-04 | 34 | 167 | 4 | CID000126484 | |
| Drug | Trimeprazine tartrate [4330-99-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 167 | 8 | 7235_DN | |
| Drug | Inhibitor 3 | 1.13e-04 | 103 | 167 | 6 | CID005327302 | |
| Drug | EACA | 1.28e-04 | 151 | 167 | 7 | CID000000564 | |
| Drug | AC1NPX1L | 1.33e-04 | 14 | 167 | 3 | CID005165851 | |
| Drug | CoA persulfide | 1.33e-04 | 14 | 167 | 3 | CID000174251 | |
| Drug | CI-924 | 1.33e-04 | 14 | 167 | 3 | CID000127627 | |
| Drug | Phenytoin | 1.34e-04 | 385 | 167 | 11 | ctd:D010672 | |
| Drug | diisopropyl | 1.37e-04 | 36 | 167 | 4 | CID000006589 | |
| Disease | venous thromboembolism, factor VII measurement | 2.29e-06 | 38 | 166 | 5 | EFO_0004286, EFO_0004619 | |
| Disease | venous thromboembolism, von Willebrand factor measurement | 3.81e-06 | 42 | 166 | 5 | EFO_0004286, EFO_0004629 | |
| Disease | venous thromboembolism, plasminogen activator inhibitor 1 measurement | 5.37e-06 | 21 | 166 | 4 | EFO_0004286, EFO_0004792 | |
| Disease | venous thromboembolism, tissue plasminogen activator measurement | 7.87e-06 | 23 | 166 | 4 | EFO_0004286, EFO_0004791 | |
| Disease | factor XI measurement, venous thromboembolism | 2.36e-05 | 30 | 166 | 4 | EFO_0004286, EFO_0004694 | |
| Disease | Mesenteric Venous Thrombosis | 3.15e-05 | 2 | 166 | 2 | C0267412 | |
| Disease | von Willebrand's disease 2 (is_marker_for) | 3.15e-05 | 2 | 166 | 2 | DOID:0060574 (is_marker_for) | |
| Disease | Occlusive Mesenteric Arterial Ischemia | 3.15e-05 | 2 | 166 | 2 | C3852985 | |
| Disease | Acute Mesenteric Arterial Embolus | 3.15e-05 | 2 | 166 | 2 | C3852984 | |
| Disease | Acute Mesenteric Arterial Thrombosis | 3.15e-05 | 2 | 166 | 2 | C3852987 | |
| Disease | Nonocclusive Mesenteric Ischemia | 3.15e-05 | 2 | 166 | 2 | C3852986 | |
| Disease | level of chymotrypsinogen B2 in blood serum | 3.15e-05 | 2 | 166 | 2 | OBA_2041192 | |
| Disease | Mesenteric vascular insufficiency | 3.15e-05 | 2 | 166 | 2 | C1412000 | |
| Disease | factor VIII measurement, venous thromboembolism | 3.93e-05 | 34 | 166 | 4 | EFO_0004286, EFO_0004630 | |
| Disease | thrombosis (is_implicated_in) | 7.57e-05 | 15 | 166 | 3 | DOID:0060903 (is_implicated_in) | |
| Disease | chymotrypsinogen B measurement | 9.40e-05 | 3 | 166 | 2 | EFO_0801477 | |
| Disease | folic acid measurement | 1.31e-04 | 46 | 166 | 4 | EFO_0005111 | |
| Disease | Deep Vein Thrombosis | 2.16e-04 | 21 | 166 | 3 | C0149871 | |
| Disease | Venous Thrombosis | 2.16e-04 | 21 | 166 | 3 | C0042487 | |
| Disease | mean platelet volume | VWF STARD8 MYO1E ACOX1 EML6 FBRSL1 DYNC2I1 FRYL ZFPM2 TRANK1 TNRC6A ZBTB10 UBASH3B TASOR DSE GP5 | 2.20e-04 | 1020 | 166 | 16 | EFO_0004584 |
| Disease | complement C2 measurement | 3.11e-04 | 5 | 166 | 2 | EFO_0020274 | |
| Disease | pulmonary embolism (is_implicated_in) | 3.11e-04 | 5 | 166 | 2 | DOID:9477 (is_implicated_in) | |
| Disease | STROKE, ISCHEMIC | 3.11e-04 | 5 | 166 | 2 | 601367 | |
| Disease | Ischemic stroke | 3.11e-04 | 5 | 166 | 2 | cv:C0948008 | |
| Disease | autosomal recessive limb-girdle muscular dystrophy (is_implicated_in) | 3.11e-04 | 5 | 166 | 2 | DOID:0110274 (is_implicated_in) | |
| Disease | pulse pressure measurement | PAPPA2 FOXO3 FNDC3B MYO1E ACOX1 FBRSL1 TNRC6B FRYL GDF10 ZFPM2 TRANK1 PKD1 TNRC6A SF3A3 PITPNM3 LOXL4 FGR MBD5 NDRG4 | 3.29e-04 | 1392 | 166 | 19 | EFO_0005763 |
| Disease | dietary heme iron intake measurement, type 2 diabetes mellitus | 4.65e-04 | 6 | 166 | 2 | EFO_0008355, MONDO_0005148 | |
| Disease | venous thromboembolism, fibrinogen measurement | 5.62e-04 | 67 | 166 | 4 | EFO_0004286, EFO_0004623 | |
| Disease | colorectal cancer (implicated_via_orthology) | 6.35e-04 | 30 | 166 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | peripheral vascular disease | 6.49e-04 | 7 | 166 | 2 | EFO_0003875 | |
| Disease | retinal vein occlusion (is_implicated_in) | 6.49e-04 | 7 | 166 | 2 | DOID:1727 (is_implicated_in) | |
| Disease | autism spectrum disorder (is_marker_for) | 6.49e-04 | 7 | 166 | 2 | DOID:0060041 (is_marker_for) | |
| Disease | focal segmental glomerulosclerosis (is_marker_for) | 8.61e-04 | 8 | 166 | 2 | DOID:1312 (is_marker_for) | |
| Disease | Thrombophilia due to thrombin defect | 8.61e-04 | 8 | 166 | 2 | cv:C3160733 | |
| Disease | Venous Thromboembolism | 8.61e-04 | 8 | 166 | 2 | C1861172 | |
| Disease | diet measurement | MFSD6 LAMA2 TNRC6B F2 GDF10 ZFPM2 FRK PTPA NTNG2 TRANK1 TNRC6A PKHD1 PRKDC MBD5 PADI2 | 8.97e-04 | 1049 | 166 | 15 | EFO_0008111 |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 1.10e-03 | 9 | 166 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | Thrombophilia | 1.10e-03 | 9 | 166 | 2 | C0398623 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.13e-03 | 206 | 166 | 6 | C0152013 | |
| Disease | platelet component distribution width | FOXO3 FLT4 VWF STARD8 ZFPM2 NEU1 TRANK1 ZBTB10 MLH1 VAV2 MYBPC1 GP5 | 1.22e-03 | 755 | 166 | 12 | EFO_0007984 |
| Disease | venous thromboembolism | 1.24e-03 | 460 | 166 | 9 | EFO_0004286 | |
| Disease | osteonecrosis (is_implicated_in) | 1.37e-03 | 10 | 166 | 2 | DOID:10159 (is_implicated_in) | |
| Disease | sexual dimorphism measurement | PAPPA2 FOXO3 FNDC3B TMPRSS12 FRYL GAL FRK TRANK1 SCARB1 PKD1 TNRC6A ADAMTS17 SF3A3 TASOR DSE | 1.51e-03 | 1106 | 166 | 15 | EFO_0021796 |
| Disease | kidney disease (implicated_via_orthology) | 1.59e-03 | 41 | 166 | 3 | DOID:557 (implicated_via_orthology) | |
| Disease | age-related macular degeneration | 1.63e-03 | 89 | 166 | 4 | EFO_0001365 | |
| Disease | Posterior Choroidal Artery Infarction | 1.67e-03 | 11 | 166 | 2 | C0887799 | |
| Disease | Jeune thoracic dystrophy | 1.67e-03 | 11 | 166 | 2 | C0265275 | |
| Disease | Cerebral Infarction, Left Hemisphere | 1.67e-03 | 11 | 166 | 2 | C0751010 | |
| Disease | Anterior Choroidal Artery Infarction | 1.67e-03 | 11 | 166 | 2 | C0751012 | |
| Disease | Cerebral Infarction, Right Hemisphere | 1.67e-03 | 11 | 166 | 2 | C0751011 | |
| Disease | Subcortical Infarction | 1.67e-03 | 11 | 166 | 2 | C0751014 | |
| Disease | Cerebral Infarction | 1.67e-03 | 11 | 166 | 2 | C0007785 | |
| Disease | factor VIII deficiency (is_implicated_in) | 1.67e-03 | 11 | 166 | 2 | DOID:12134 (is_implicated_in) | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 1.67e-03 | 11 | 166 | 2 | DOID:9279 (implicated_via_orthology) | |
| Disease | trypsin-2 measurement | 1.67e-03 | 11 | 166 | 2 | EFO_0008305 | |
| Disease | Congenital muscular dystrophy | 2.00e-03 | 12 | 166 | 2 | cv:C0699743 | |
| Disease | Thromboembolism | 2.00e-03 | 12 | 166 | 2 | C0040038 | |
| Disease | Adenocarcinoma of large intestine | 2.15e-03 | 96 | 166 | 4 | C1319315 | |
| Disease | Thrombus | 2.22e-03 | 46 | 166 | 3 | C0087086 | |
| Disease | Familial idiopathic steroid-resistant nephrotic syndrome | 2.36e-03 | 13 | 166 | 2 | cv:C4273714 | |
| Disease | Liver carcinoma | 2.39e-03 | 507 | 166 | 9 | C2239176 | |
| Disease | Thrombosis | 2.66e-03 | 49 | 166 | 3 | C0040053 | |
| Disease | urinary metabolite measurement | 2.71e-03 | 245 | 166 | 6 | EFO_0005116 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 2.74e-03 | 14 | 166 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | glucose-dependent insulinotropic peptide measurement, glucose tolerance test | 2.74e-03 | 14 | 166 | 2 | EFO_0004307, EFO_0008464 | |
| Disease | polycystic kidney disease (implicated_via_orthology) | 2.74e-03 | 14 | 166 | 2 | DOID:0080322 (implicated_via_orthology) | |
| Disease | systemic scleroderma (is_marker_for) | 3.33e-03 | 53 | 166 | 3 | DOID:418 (is_marker_for) | |
| Disease | interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement | 3.58e-03 | 16 | 166 | 2 | EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293 | |
| Disease | Tetralogy of Fallot | 3.58e-03 | 16 | 166 | 2 | C0039685 | |
| Disease | myopia (is_implicated_in) | 3.58e-03 | 16 | 166 | 2 | DOID:11830 (is_implicated_in) | |
| Disease | Blood Coagulation Disorders | 3.58e-03 | 16 | 166 | 2 | C0005779 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 3.58e-03 | 16 | 166 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | body surface area | PAPPA2 FOXO3 FNDC3B GAL TNRC6A ADAMTS17 SF3A3 PKHD1 TASOR ECE2 | 3.60e-03 | 643 | 166 | 10 | EFO_0022196 |
| Disease | leukemia | 3.70e-03 | 55 | 166 | 3 | C0023418 | |
| Disease | 3-hydroxypropylmercapturic acid measurement | 3.90e-03 | 352 | 166 | 7 | EFO_0007014 | |
| Disease | muscular dystrophy (is_implicated_in) | 4.05e-03 | 17 | 166 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Ischemic stroke, venous thromboembolism, stroke, Abnormal thrombosis, deep vein thrombosis, pulmonary embolism | 4.05e-03 | 17 | 166 | 2 | EFO_0000712, EFO_0003827, EFO_0003907, EFO_0004286, HP_0001977, HP_0002140 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 4.54e-03 | 18 | 166 | 2 | EFO_1000649, HP_0000131 | |
| Disease | Hydrops Fetalis | 5.05e-03 | 19 | 166 | 2 | C0020305 | |
| Disease | type 1 diabetes mellitus (biomarker_via_orthology) | 5.05e-03 | 19 | 166 | 2 | DOID:9744 (biomarker_via_orthology) | |
| Disease | temporal lobe epilepsy (is_marker_for) | 5.59e-03 | 20 | 166 | 2 | DOID:3328 (is_marker_for) | |
| Disease | brain age measurement | 5.59e-03 | 20 | 166 | 2 | EFO_0010602 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GEQLLASEPSWWTTG | 416 | Q9H993 | |
| VPGSWPWQVSLQDKT | 41 | Q6GPI1 | |
| VVKVSTCWEGPWQGR | 536 | Q9HCM7 | |
| TATKWWPGDLGRSAT | 186 | Q99424 | |
| KPIGWDTDISWLTGE | 206 | P15056 | |
| VTWPDESKAGGSWDL | 456 | P22792 | |
| SWWPEFSVNKPVIGS | 681 | O15254 | |
| PQTLSRGWGDDITWV | 31 | Q8TD06 | |
| NWTEIEGSKLVPFWS | 281 | Q9Y673 | |
| NKQDGTPLSWWVGRT | 691 | Q9C0A0 | |
| GWSFSVLTEPGVWKV | 136 | Q8N1L1 | |
| ILSDWLGSQWGKAPS | 431 | Q008S8 | |
| TGIQWGTWTKNNSPV | 356 | Q86XS5 | |
| GDAWKTKLGEPWVSI | 136 | Q8IVJ8 | |
| PAATWRTWGQESKVL | 166 | Q495Z4 | |
| WEAWKALGDSSPSQA | 96 | Q9BR61 | |
| PGGQKWVSRWASLAD | 656 | Q9Y4F5 | |
| PTWQWATGEELKVKA | 51 | Q9NT62 | |
| EWVKGRNPSDLSWSS | 416 | Q8TE56 | |
| PETWIWDLVVVNSAG | 736 | P01023 | |
| TSWGDVSLWEPSGKK | 51 | Q6IQ32 | |
| SWVLWKDIQTGATGS | 86 | Q9Y483 | |
| TWDPGTDTALGWSKQ | 256 | Q99650 | |
| KPQQGLPEVAESTWW | 41 | Q8WWR9 | |
| VASLSWQTEWTPGQA | 926 | Q7RTW8 | |
| LQWLKNGQPVSTAWG | 276 | O60500 | |
| WVQVLSEGWATPLKG | 256 | O95340 | |
| KLDTITWTWQGPGAL | 241 | Q8NF37 | |
| VRLPDGWSQVCDKGW | 191 | P58215 | |
| KETWFWSGTPRAQEV | 476 | Q96JB6 | |
| KGIWVGTESQDVPWE | 291 | Q9NPI8 | |
| DVWLGTWNGSTKVAV | 276 | P09769 | |
| TVPTAMWTGGQDWLS | 346 | Q5VYY2 | |
| LWAEPGSVISWGNSV | 31 | Q8NHJ6 | |
| SILDSWVWGKQPDVN | 96 | O95714 | |
| SLWRVNVGDPKSQWG | 516 | P06681 | |
| TQEKSGWVECWTVPS | 641 | Q2LD37 | |
| PDVTRIGPSQEKWGW | 1876 | Q2LD37 | |
| WTIQWPTTETGKENN | 166 | Q6VAB6 | |
| TAGPKWLLDVTWQGV | 151 | Q8WW38 | |
| EGDNGWIPETVEEWK | 1016 | Q9UPZ3 | |
| DNTGKAPGWFVDWVE | 1041 | Q8IVV2 | |
| GSSVWWKLDQRPGGE | 336 | Q8WVS4 | |
| ADIGWNEWIISPKSF | 386 | P55107 | |
| EKIGGWNITGPWDQD | 246 | P0DPD6 | |
| VKVWGNVGTVEWADP | 311 | O60506 | |
| EAGGTNVTKAWVQPW | 291 | A0A0J9YXQ4 | |
| WDQDGKGPSIWDVFT | 56 | Q6UWM7 | |
| GSWWKKELSGSSSAP | 1071 | O15018 | |
| QAWDTPTIVSRKEWG | 16 | Q96LB9 | |
| GSWDQTVKLWDPTVG | 131 | O00628 | |
| ENVWTTLADGWPKNL | 1386 | O94915 | |
| QGQATGILEWPFWTK | 186 | Q5T0T0 | |
| SPWVGQVTEDCSSKW | 496 | Q9UL01 | |
| NAIDGKNTWWQSPSI | 101 | P24043 | |
| GSINAWSTKEPFSWI | 2076 | P00451 | |
| IVGDWWEQPGQAALS | 591 | O94927 | |
| KKASWTWGPEGQGAI | 136 | Q9Y2J8 | |
| EDVNKPAWGVSSSPW | 681 | Q6ZSS7 | |
| DSTALWWVIKGPVVG | 301 | P41586 | |
| VGASVWPKKGTAVFW | 471 | P13674 | |
| LAGAATWPWDKDAVT | 696 | Q9BXP8 | |
| ETGKNWIEGEEWCLP | 531 | B2RXH4 | |
| PTVRVGWNEINTAWG | 276 | A8MW95 | |
| GEVWEGLWNNTTPVA | 246 | P42685 | |
| TSIKWWPGGLGKTSN | 171 | Q15067 | |
| WKWRDQDGSPQGEGT | 1286 | Q9ULT8 | |
| VEGLQGQTWAPDWVE | 406 | A1L0T0 | |
| FLWVGSDSWGAKTSP | 301 | O15303 | |
| VQWIWGGYSVDSPTL | 161 | P00156 | |
| QSPDVPVSWWQGSGK | 46 | Q96N68 | |
| GTSWEPTQEAPLWVN | 146 | P15813 | |
| AGITWVTLQWSKPEG | 486 | Q53EP0 | |
| SAGLWSPAKEKRGWT | 21 | P22466 | |
| VKNLEWIAGGTWTPS | 691 | P12110 | |
| KPLQGEFTTWSPWSQ | 211 | P14784 | |
| RSDVPFWAIKNSWGT | 441 | Q9UBX1 | |
| TLPIWAASKVNGWIF | 91 | P25024 | |
| GTASVRGEWPWQVTL | 391 | P03951 | |
| DWGPSFPTQGIWKDV | 191 | O00462 | |
| GDLVWGQIKGLTSWP | 1386 | Q9P267 | |
| SWDSTVKVWSGVPAE | 731 | Q92636 | |
| PNVEGAAKLLWSEWT | 381 | Q9BVP2 | |
| SEPWVWAQPVTTGKG | 501 | P40197 | |
| WASWTSVLGDEVIGI | 1861 | Q6ZMW3 | |
| GVWWPQTKFGVLATV | 2136 | Q9NYQ7 | |
| LGRQEWSGPWSEISE | 286 | Q9Y6Q1 | |
| VNFKSWWVGDIPVSG | 36 | Q1ZYL8 | |
| VPGSWPWQVSLQDKT | 41 | P17538 | |
| TWKEEWEKGVQVPAS | 71 | Q92613 | |
| QPGWTSWGNEVLKFQ | 446 | Q8N3J2 | |
| RPVSWGAQISWKQAD | 226 | Q5SR56 | |
| QWPGVKLRVTEGWDE | 121 | Q14623 | |
| SKGPDTWREWSSDGK | 536 | P42702 | |
| IWGKDRSWTGQELSP | 1396 | O94851 | |
| KSLVCWPSGEGTLSW | 3406 | P98161 | |
| AKVVRGPDWEWGSQD | 161 | Q96AX9 | |
| ICKSWVTTDEGPTWE | 21 | Q96CW9 | |
| VISDEGGWWKAISLS | 51 | Q13239 | |
| PEAIIGSWLWATEES | 716 | Q5JY77 | |
| TPWVKSPTGSWQKEA | 796 | Q9P2B2 | |
| EGTGKSSWWIINPDG | 226 | O43524 | |
| SSWWIINPDGGKSGK | 231 | O43524 | |
| QVWAVNSAGKAPSSW | 4711 | O75445 | |
| TWKGSIAEWSSGSPV | 76 | Q96L08 | |
| PKDWVGIFKVGWSTA | 46 | Q86VP1 | |
| QWPGVKLRVTEGWDE | 116 | Q15465 | |
| QSAKLWGTGGRAWEP | 266 | Q8IUW3 | |
| TLADIWPLGKTWSQE | 601 | O60522 | |
| ELTPKDQCWVTGWGA | 186 | A6NIE9 | |
| GSSGKVLPKWGWEQL | 486 | Q9UKY4 | |
| ASKPGWWLLNTEVGE | 1876 | P12259 | |
| GAVIDWPTEEGKEVW | 26 | Q9HB40 | |
| SNGTSWRKETVQLWP | 351 | Q99519 | |
| SWTAENFWLDPAVKG | 71 | Q8IYI0 | |
| GKGASDRTLWPTAAW | 486 | Q8WTV0 | |
| PNGKGWIDWAATKLS | 141 | Q9ULP0 | |
| TWLGAPIQFAWQKTS | 11 | Q8NEZ3 | |
| ESALKWSLPETWQGV | 2731 | P08F94 | |
| DWSKLGSPQVWIDAG | 296 | P48029 | |
| GDAKWIQSVPIWERS | 61 | Q06520 | |
| QSEVPGSIPNSWKWT | 701 | P40692 | |
| IKWFDGTPTDQSNWG | 1326 | Q13018 | |
| GANTRKAWEAWPVAS | 191 | Q92502 | |
| TFLEELSTPEGKWQW | 1351 | Q9UK61 | |
| TTPEKWDGVSRSWQN | 1426 | Q8N3C0 | |
| TWNVKASPEKGAETW | 211 | O75503 | |
| LSDPEGAWKWVDGTD | 241 | Q8IUN9 | |
| SREQGQPWKWINGTE | 136 | Q9UHP7 | |
| VEGQWQWVDGTPLTK | 146 | Q9ULY5 | |
| TWTPGKVATWLRGLD | 6 | Q969H4 | |
| IPSTEGEGSGSWKWK | 636 | Q7Z2D5 | |
| ATTQANGGWPSGWEK | 546 | Q9P2U8 | |
| GWDTSTWGLKSNTEP | 56 | P82094 | |
| GLKGAWKNSVEEWTT | 246 | Q5T6F2 | |
| SNWGTQKIVEWKPGT | 71 | A8MXK1 | |
| SGGPLVTSKNNIWWL | 441 | O15393 | |
| IVGGALASDSKWPWQ | 326 | Q9BYE2 | |
| WNGPKWTFTVLGSST | 456 | Q7RTX1 | |
| QSSWKSVGSQWASPE | 2511 | P04275 | |
| VNGKSSLEGAWPWQA | 186 | Q86T26 | |
| TWNGPWVSTEVLAAA | 141 | P51571 | |
| WNISAVPSWSKVNQG | 311 | Q15257 | |
| PSELQAAGWVGWQEV | 101 | Q6NVU6 | |
| SQSSVLWPDGQEVVW | 171 | P35916 | |
| WKSGPVVSLGWSAEE | 81 | Q9H269 | |
| VGWDALKLNWTAPEG | 1176 | P24821 | |
| ATPLWIIGWGFTKQN | 321 | Q9NRS4 | |
| GTEAQAGAWPWVVSL | 81 | Q86WS5 | |
| SPGPLATVQGWWETK | 256 | P0DPE3 | |
| IITVLDDSDPNWWKG | 236 | Q92783 | |
| GPSAWQNWTYEVKVS | 601 | P08922 | |
| DGTVWTKVGWEILPE | 26 | A0A1B0GTY4 | |
| NPAEWTGSVAILKQW | 251 | O43548 | |
| PVGASRITAKWWGSK | 536 | Q9BZ71 | |
| ATDPNILGRTWEGWE | 4111 | P78527 | |
| AGNPDGWEWIKAVIT | 76 | Q96SE7 | |
| VTGWGNLKETWTANV | 501 | P00734 | |
| WENGTFPGWPKETSS | 221 | Q12874 | |
| PESWPKQETWENGES | 701 | Q96DT7 | |
| EPGLFEWTKWVAGST | 496 | Q8TF42 | |
| WKGETNGRIGWFPST | 856 | P52735 | |
| IGWSAQEESTIPSWQ | 1231 | O15050 | |
| WGPITRWEAEGKLAN | 386 | O14544 | |
| SGWGQTPIKQNTAWD | 721 | Q8NDV7 | |
| WKQPTGSDELKIGEW | 511 | Q9UPQ9 | |
| STEWKDPKNTGGWND | 686 | Q9UPQ9 | |
| ARLSWTWGEQTVGPS | 371 | A6NMB1 | |
| RVEPGIFEWTKWEAG | 506 | P57075 | |
| WPWAKQQSSLEGGDR | 1181 | Q70EL1 | |
| SKWGVEASPGKAWER | 6 | Q9H5J0 | |
| GFVWKQLSGEEVSWS | 621 | Q5T447 | |
| KNSLFGSVETWPWQV | 6 | Q9NRV9 | |
| GSVETWPWQVLSKGD | 11 | Q9NRV9 | |
| KATWPSWQGEEKQGV | 641 | Q12965 | |
| DDNKVLWGSWSVLGP | 261 | Q6IQ20 | |
| EDVWGENVALTWTPP | 941 | Q00872 | |
| KSVWSRLDGQWPDGL | 301 | Q9NQS3 |